Skip to main content

Table 3 Multivariable regression models for the association between AGEs levels and atherosclerotic lipid profiles with gender-specificaiton.

From: Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients

  

Model I

Model II

Model III

  

β(S.E)

β(S.E)

β(S.E)

Males

    
 

CHOL(mg/dL)

7.9(2.5)**

7.7(2.5)**

7.4(2.6)**

 

TG(mg/dL)

48.4(4.7)***

48.6(4.8)***

47.2(4.7)***

 

HDL-C(mg/dL)

-2.7(0.6)***

-2.4(0.6)***

-2.3(0.6)***

 

LDL-C(mg/dL)

2.7(2.1)

2.3(2.1)

2.0(2.1)

 

CHOL/HDL-C

0.4(0.1)***

0.4(0.1)***

0.4(0.1)***

 

LDL-C/HDL-C

0.2(0.1)**

0.2(0.1)**

0.2(0.1)**

 

TG/HDL-C

1.4(0.1)***

1.4(0.1)***

1.3(0.1)***

 

AI

0.8(0.1)***

0.8(0.1)***

0.8(0.1)***

Females

    
 

CHOL(mg/dL)

8.3(1.9)***

8.4(2.0)***

7.6(1.9)***

 

TG(mg/dL)

41.8(3.4)***

40.9(3.4)***

40.0(3.4)***

 

HDL-C(mg/dL)

-3.1(0.7)***

-3.0(0.7)***

-3.0(0.7)***

 

LDL-C(mg/dL)

4.9(1.8)**

5.1(1.9)**

4.3(1.8)*

 

CHOL/HDL-C

0.4(0.1)***

0.4(0.1)***

0.4(0.1)***

 

LDL-C/HDL-C

0.2(< 0.1)***

0.2(< 0.1)***

0.2(< 0.1)***

 

TG/HDL-C

1.1(0.1)***

1.0(0.1)***

1.0(0.1)***

 

AI

0.7(0.1)***

0.7(0.1)***

0.7(0.1)***

  1. Model I: after adjusting for age(yrs)
  2. Model II: after further adjusting for age(yrs) and BMI
  3. Model III: after further adjusting for age(yrs), BMI, fasting glucose and HbA1c
  4. *p < 0.05 **p < 0.01 ***p < 0.001
  5. BMI: body mass index; AGEs: advanced glycation end products; HbA1c: hemoglobin A1c; CHOL: cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein-cholesterol; LDL-C: low density lipoprotein-cholesterol; AI: atherosclerotic index